Bank of Montreal’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,077
| Closed | -$680K | – | 5227 |
|
|
2020
Q3 | $680K | Sell |
3,077
-1,606
| -34% | -$171K | ﹤0.01% | 2178 |
|
|
2020
Q2 | $436K | Buy |
4,683
+4,356
| +1,332% | +$363K | ﹤0.01% | 2330 |
|
|
2020
Q1 | $15K | Sell |
327
-5,484
| -94% | -$351K | ﹤0.01% | 3362 |
|
|
2019
Q4 | $424K | Buy |
5,811
+1,713
| +42% | +$104K | ﹤0.01% | 2768 |
|
|
2019
Q3 | $213K | Sell |
4,098
-145
| -3% | -$7.71K | ﹤0.01% | 2867 |
|
|
2019
Q2 | $212K | Sell |
4,243
-23,839
| -85% | -$1.16M | ﹤0.01% | 2889 |
|
|
2019
Q1 | $1.46M | Buy |
28,082
+27,529
| +4,978% | +$1.27M | ﹤0.01% | 1845 |
|
|
2018
Q4 | $27K | Buy |
553
+230
| +71% | +$12.7K | ﹤0.01% | 3542 |
|
|
2018
Q3 | $21K | Buy |
323
+89
| +38% | +$5.23K | ﹤0.01% | 3700 |
|
|
2018
Q2 | $12K | Buy |
234
+214
| +1,070% | +$10.4K | ﹤0.01% | 3920 |
|
|
2018
Q1 | $1K | Sell |
20
-2,990
| -99% | -$155K | ﹤0.01% | 4126 |
|
|
2017
Q4 | $127K | Sell |
3,010
-990
| -25% | -$38.1K | ﹤0.01% | 2908 |
|
|
2017
Q3 | $171K | Buy |
+4,000
| New | +$128K | ﹤0.01% | 2732 |
|
Bank of Montreal's MYOK Position: Q4 2020 in Review
Bank of Montreal sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 3,077 shares — an estimated $680K sold.
Bank of Montreal first reported a position in MYOK in Q3 2017 and held it in 13 quarters. The position peaked at $1.46M in Q1 2019. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Bank of Montreal reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Bank of Montreal sold 3,077 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $680K.
- Bank of Montreal first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
- Bank of Montreal's MyoKardia, Inc. Common Stock position peaked at $1.46M in Q1 2019.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.